Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SomaLogic, Inc. (SLGC : NSDQ)

• Company Description    SomaLogic Inc. provides AI-data driven proteomics technology. SomaLogic Inc., formerly known as CM Life Sciences II Inc., is based in NEW YORK. Number of Employees: 320

• Price / Volume Information    Yesterday's Closing Price: $2.21 Daily Weekly Monthly 20 Day Moving Average: 971,362 shares Shares Outstanding: 183.45 (millions) Market Capitalization: $405.43 (millions) Beta: 1.88 52 Week High: $8.50 52 Week Low: $2.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -28.48% -26.17% 12 Week -6.36% -8.89% Year To Date -11.95% -14.45%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2945 WILDERNESS PLACE - BOULDER,CO 80301 USA ph: 303-625-9000 fax: - investors@somalogic.com http://www.somalogic.com

• General Corporate Information    Officers Roy Smythe - Chief Executive Officer Shaun Blakeman - Chief Financial Officer Robert Barchi - Director Eli Casdin - Director Troy Cox - Director Peer Information SomaLogic, Inc. (EVOL) SomaLogic, Inc. (RAMP) SomaLogic, Inc. (ALOT) SomaLogic, Inc. (TGHI) SomaLogic, Inc. (GNCMA) SomaLogic, Inc. (GSIC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Technology Services Sector: Business Services CUSIP: 83444K105 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/22 Next Expected EPS Date: 03/28/23 Share - Related Items Shares Outstanding: 183.45 Most Recent Split Date: (:1) Beta: 1.88 Market Capitalization: $405.43 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.43 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/28/23

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.67 Price/Cash Flow: - Price / Sales: 3.98 EPS Growth vs. Year Ago Period: 45.45% vs. Previous Quarter: -38.46% Sales Growth vs. Year Ago Period: 108.65% vs. Previous Quarter: 194.92% ROE 12/31/22 - - 09/30/22 - -18.23 06/30/22 - -16.76 ROA 12/31/22 - - 09/30/22 - -15.92 06/30/22 - -14.61 Current Ratio 12/31/22 - - 09/30/22 - 14.56 06/30/22 - 18.86 Quick Ratio 12/31/22 - - 09/30/22 - 14.12 06/30/22 - 18.26 Operating Margin 12/31/22 - - 09/30/22 - -109.16 06/30/22 - -128.78 Net Margin 12/31/22 - - 09/30/22 - -81.72 06/30/22 - -114.46 Pre-Tax Margin 12/31/22 - - 09/30/22 - -82.33 06/30/22 - -114.46 Book Value 12/31/22 - - 09/30/22 - 3.29 06/30/22 - 3.31 Inventory Turnover 12/31/22 - - 09/30/22 - 2.53 06/30/22 - 2.67 Debt-to-Equity 12/31/22 - - 09/30/22 - 0.00 06/30/22 - 0.00 Debt-to-Capital 12/31/22 - - 09/30/22 - 0.00 06/30/22 - 0.00

Powered by Zacks Investment Research ©